email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
2221 - 2235
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
Jiuzhou Pharma Pays $16 Million to Acquire US-based API CDMO
$5.00
Available
Stroke Medical of Shanghai Lands $14 Million for Medical Devices
$5.00
Available
Hansoh Forms $1.5 Billion Partnership with Atomwise, an AI Drug Discovery Company
$5.00
Available
Genenta Science of Milan Raises $14.6 Million in Funding Led by China Investor
$5.00
Available
Gracell Reports Positive Results from FasT CAR-19 Cell Gene Therapy
$5.00
Available
Cellular Bio Starts China Trial of Stem Cell Treatment for Arthritic Knees
$5.00
Available
Henlius Biotech Prices Hong Kong IPO to Raise $477 Million
$5.00
Available
SoliPharma of Hangzhou Raises $36.5 Million to Develop High End Generics
$5.00
Available
Insilico Closes $37 Million Series B for AI Drug Discovery from China Investors
$5.00
Available
I-Mab to Test its CD73 Antibody in Combination with Junshi's PD-1 mAb
$5.00
Available
Sichuan Clover Doses First Patient in China Trial of Novel Cancer Biologic
$5.00
Available
CANbridge Granted China Priority Review for Rare Disease Treatment
$5.00
Available
JHL Biotech Settles IP Suit with Genentech, Discontinuing Development of Four Genentech Biosimilars
$5.00
Available
Laviana Raises $14 Million for CDMO Operations in China
$5.00
Available
AstraZeneca, Wuxi City Partner to Open New China Life Science Park
$5.00
Available